Updated Jul 16, 2026
Patel Chirag K. is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days.
Chirag K. Patel is an executive in the pharmaceutical industry, currently serving as the President and Co-CEO of Amneal Pharmaceuticals, Inc. He has been instrumental in the company's growth and development, focusing on providing high-quality generic and specialty pharmaceuticals.
| Role | President & Co-CEO, Director |
|---|---|
| Notability | 75/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-03-05 | AMRX | Amneal Pharmaceuticals, Inc. | F — Tax withholding / forfeiture | 37.8K | $13.30 | $503K |
| 2026-03-05 | AMRX | Amneal Pharmaceuticals, Inc. | M — Option exercise | 92.6K | — | |
| 2026-03-05 | AMRX | Amneal Pharmaceuticals, Inc. | F — Tax withholding / forfeiture | 297.5K | $13.31 | $3.96M |
| 2026-03-05 | AMRX | Amneal Pharmaceuticals, Inc. | M — Option exercise | 733.9K | — | |
| 2026-03-05 | AMRX | Amneal Pharmaceuticals, Inc. | F — Tax withholding / forfeiture | 15.6K | $13.31 | $208K |
| 2026-03-05 | AMRX | Amneal Pharmaceuticals, Inc. | M — Option exercise | 59.9K | — |
Chirag K. Patel is an executive in the pharmaceutical industry, currently serving as the President and Co-CEO of Amneal Pharmaceuticals, Inc. He has been instrumental in the company's growth and development, focusing on providing high-quality generic and specialty pharmaceuticals.…
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Patel Chirag K. profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.